Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide
about
Amyloid-mediated sequestration of essential proteins contributes to mutant huntingtin toxicity in yeastDocosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease modelsRationally designed turn promoting mutation in the amyloid-β peptide sequence stabilizes oligomers in solutionMild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregationVitamin A and Alzheimer's diseaseAPP binds DR6 to trigger axon pruning and neuron death via distinct caspasesQuantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's diseaseThe coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathwayExtracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease.Effect of N-homocysteinylation on physicochemical and cytotoxic properties of amyloid β-peptideSRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cellsCharacterizing affinity epitopes between prion protein and β-amyloid using an epitope mapping immunoassayClose association of water channel AQP1 with amyloid-beta deposition in Alzheimer disease brainsTransmembrane protein 147 (TMEM147) is a novel component of the Nicalin-NOMO protein complexPumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levelsAmyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastinHsp90-Tau complex reveals molecular basis for specificity in chaperone actionGeneration of amyloid-β is reduced by the interaction of calreticulin with amyloid precursor protein, presenilin and nicastrinThe ER stress factor XBP1s prevents amyloid-beta neurotoxicityEvidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusibApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recyclingAbeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61Protein phosphatases and Alzheimer's diseaseMechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disordersDiagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer diseaseLipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in miceReelin signaling antagonizes beta-amyloid at the synapseMicroRNA: Implications for Alzheimer Disease and other Human CNS DisordersAmyloids: friend or foe?Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differencesEffects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicityInduction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic miceSynapses and Alzheimer's diseaseUnderstanding synapses: past, present, and futureNeural stem/progenitor cells in Alzheimer's diseaseAmyloidosis in Retinal Neurodegenerative DiseasesTethered and Polymer Supported Bilayer Lipid Membranes: Structure and FunctionNon-ionotropic signaling by the NMDA receptor: controversy and opportunityAmyloid-β-Induced Dysregulation of AMPA Receptor TraffickingOverview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds
P2860
Q21134910-920A03FE-6A91-45A8-B56B-5C1BEB763D0FQ21135583-BCD45735-CA3A-4065-8F8A-FB364979059DQ21560956-A5FED811-2571-4285-820E-A0AF3E919DE9Q22001058-6FCAEC83-3BAC-4B9F-B54E-37D4B6C5D7ADQ22242414-8B6DDFDE-9BC3-4405-9145-340855903553Q22251088-E665E7F9-CE6E-468A-8CEE-7A5EDE65C3E4Q24293094-90B16E6D-2BD7-4C58-986F-479604BE4B8CQ24294387-81A23354-5835-4107-A9A3-F6AAE1BF39DFQ24300656-8999F287-3C50-4DA8-8DA6-8003433A8489Q24300725-8EDA2374-5D9C-41C1-A913-8A238834408AQ24309440-F7C4AA26-F29A-4F1A-8F72-7B707070968BQ24313479-BBCB4FE6-9B0D-46AD-9115-28B064E5A454Q24317142-C1133A13-1840-4B22-860C-808064ACAED8Q24318823-4A5D4BE1-66D3-490D-92BD-CE62D12E33B6Q24322711-D5F141C7-A503-47A8-8531-D3E2D18A1ADDQ24337233-291654ED-E34C-4EAE-8502-DA90BBBD6A56Q24338439-30BD461E-9036-4D4A-81C4-13F533A5553BQ24338484-9CCAE4F5-3A96-4A19-9E74-9247D1568226Q24598012-EB0A229A-3045-4EE0-A444-E2CFDD156681Q24610904-9B9F71F1-9070-480C-BCB1-8E2C4D7E6CF7Q24616113-9EDAE850-B17C-4429-BC8F-45F5F88A3FFDQ24620404-ACFE0226-0140-4515-8058-7B91019D79A2Q24632495-4E6148A1-5D64-46DA-8C8B-C76BB8D81E04Q24632757-32832920-5227-45D0-A608-D1B581F741D0Q24646877-A09FCC53-A409-42E1-88A8-21FF5D0C0886Q24649564-EEB2F12E-8793-49D8-AA5B-AA8CD2D878FAQ24651028-62D7127C-1963-47E2-BEE2-44A5E94F6096Q24652987-B08B42A6-F172-4689-8338-841C1DFB268CQ24653554-F76B1A7D-8E09-4E1B-A08A-362EEBBD034EQ24653927-697720B4-55F1-4AF6-BBFD-21336B2E82FBQ24657235-2082D26D-6AB6-4351-BBA5-28300A756EC0Q24681736-FD802F1E-7806-45D2-AB17-5A8B6D799C21Q26269868-F121A32E-89BD-4C91-95E1-BF524DB0AE83Q26269897-57548A6D-E453-47B3-AF03-78DC46CF538DQ26738352-D9BB2531-8E9D-46AD-945B-5BD79C0C41C3Q26739839-13E9F47F-C971-4F64-B1C5-80B7357996C6Q26744191-BC34E0C9-F1E1-46A9-AD51-97AE4BB70197Q26745925-7924FE2A-84E0-4558-92FD-18DC94508A64Q26748723-E4CFC4D9-DB00-447B-B3F9-C8232572AF61Q26749061-FA82E8C2-3387-4514-B898-105E1DC59A85
P2860
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Soluble protein oligomers in n ...... zheimer's amyloid beta-peptide
@ast
Soluble protein oligomers in n ...... zheimer's amyloid beta-peptide
@en
Soluble protein oligomers in n ...... zheimer's amyloid beta-peptide
@nl
type
label
Soluble protein oligomers in n ...... zheimer's amyloid beta-peptide
@ast
Soluble protein oligomers in n ...... zheimer's amyloid beta-peptide
@en
Soluble protein oligomers in n ...... zheimer's amyloid beta-peptide
@nl
prefLabel
Soluble protein oligomers in n ...... zheimer's amyloid beta-peptide
@ast
Soluble protein oligomers in n ...... zheimer's amyloid beta-peptide
@en
Soluble protein oligomers in n ...... zheimer's amyloid beta-peptide
@nl
P3181
P356
P1476
Soluble protein oligomers in n ...... zheimer's amyloid beta-peptide
@en
P2093
Dennis J Selkoe
P2888
P304
P3181
P356
10.1038/NRM2101
P407
P577
2007-02-01T00:00:00Z
P5875
P6179
1027439624